Securitas AB Interim Report Q1 2024 January-March

REDDITCH, England, May 8, 2024 /PRNewswire/ -- FIRST QUARTER 2024 Net sales: MSEK 1,003 (1,127) - down -11% year-on-year wit.....»»

LUND, Sweden, April 29, 2024 /PRNewswire/ -- Janua.....»»

Strong sales perfor.....»»

STOCKHOLM, May 23, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ:CALTX) (STOCKHOLM: CALTX.....»»

ÖSTERSUND, Sweden, April 26, 2024 /PRNewswire/ -- In the first quarter of 2024, we saw an improved eco.....»»

STOCKHOLM, May 18, 2021 /PRNewswire/ -- Adverty's Programmatic Channel Gains Momentum And Inc.....»»

STOCKHOLM, May 12, 2020 /PRNewswire/ -- FINANCING AGREEMENT OF UP TO SEK 216 MILLION  PERIOD (JUL 2019-MAR 2020) Net revenue SEK 50.5.....»»

STOCKHOLM, May 7, 2020 /PRNewswire/ -- FDA and EMA endorse the advancement of cobitolimod into phase III studies "The positive responses from the regulators is an important external validation of our study results and cobitolimod's po.....»»

HUDDINGE, Sweden, May 5, 2020 /PRNewswire/ --  Positive results for MIV-818 and continu.....»»

GÖTEBORG, Sweden, April 29, 2020 /PRNewswire/ -- Events in the first quarter            Low oil.....»»

Interim report January – March 2020  January – March 2020 Net sales increased by 47 percent to SEK 1,624.2 million (1,108.8). Orga.....»»

LUND, Sweden, April 28, 2020 /PRNewswire/ --  Immunovia has today published first quarter interim report for .....»»

UPPSALA, Sweden, April 28, 2020 /PRNewswire/ -- Positive growth and strong cash flow First quarter Net sa.....»»

STOCKHOLM, April 27, 2020 /PRNewswire/ -- Record qua.....»»

LONDON, April 24, 2020 /PRNewswire/ --  First quarter highlights             Gross winnings revenue amounted to GBP 249.7 (224.4.....»»

STOCKHOLM, April 24, 2020 /PRNewswire/ -- JANUARY 1 - MARCH 31, 2020(compared with January 1 - March 31, 2019)            Net sales declined 6% to SEK 4,793m (5,076). Th.....»»

GOTHENBURG, Sweden, TORONTO and TOKYO, April 24, 2020 /PRNewswire/ --   Heliospectra AB (.....»»

First quarter in brief Active Biotech announces new direction Patent regarding use of tasquinimod in the treatment of multiple myeloma granted in Japan Events after the end of the period.....»»

STOCKHOLM, April 22, 2020 /PRNewswire/ -- Operations performing according to plan Key events during the first quarter 2020 As of today, BioArctic has not experienced any noteworthy disruptions to its operations owing to the COVID-19 pand.....»»

KUNGÄLV, Sweden, April 22, 2020 /PRNewswire/ -- PERIOD 1 JANUARY - 31 MARCH 2020        Net sales amounted to SEK 1,.....»»